Fortress Investment Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Fortress Investment Group’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-809,651	Closed	-$1.56M	–	184
2022 Q2	$1.56M	Sell	809,651 -132,607	-14%	-$289K	0.16%	21
2022 Q1	$2.8M	Hold	942,258	–	–	0.15%	24
2021 Q4	$4.23M	Buy	942,258 +508,454	+117%	+$2.41M	0.16%	77
2021 Q3	$2.11M	Hold	433,804	–	–	0.12%	133
2021 Q2	$2.96M	Hold	433,804	–	–	0.12%	101
2021 Q1	$3.06M	Hold	433,804	–	–	0.15%	65
2020 Q4	$2.72M	Hold	433,804	–	–	0.12%	61
2020 Q3	$2.35M	Hold	433,804	–	–	0.15%	33
2020 Q2	$2.26M	Hold	433,804	–	–	0.22%	14
2020 Q1	$1.37M	Hold	433,804	–	–	0.18%	20
2019 Q4	$1.75M	Hold	433,804	–	–	0.2%	34
2019 Q3	$1.87M	Hold	433,804	–	–	0.2%	32
2019 Q2	$1.73M	Hold	433,804	–	–	0.19%	29
2019 Q1	$2.33M	Hold	433,804	–	–	0.24%	25
2018 Q4	$2.23M	Hold	433,804	–	–	0.27%	17
2018 Q3	$4.21M	Hold	433,804	–	–	0.41%	13
2018 Q2	$4.42M	Hold	433,804	–	–	0.18%	15
2018 Q1	$5.64M	Hold	433,804	–	–	0.14%	15
2017 Q4	$7.77M	Hold	433,804	–	–	0.2%	14
2017 Q3	$10.9M	Hold	433,804	–	–	0.24%	13
2017 Q2	$10.5M	Hold	433,804	–	–	0.21%	11
2017 Q1	$8.35K	Hold	433,804	–	–	0.03%	14
2016 Q4	$6.68M	Hold	433,804	–	–	0.16%	13
2016 Q3	$5.64M	Hold	433,804	–	–	0.12%	14
2016 Q2	$6.03M	Hold	433,804	–	–	0.16%	25
2016 Q1	$6.58M	Buy	+433,804	New	+$6.63M	0.15%	31

Other funds holding PRTK

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

1CM

1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return

Fortress Investment Group's PRTK Position: Q3 2022 in Review

Fortress Investment Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2022, closing a stake of 809,651 shares — an estimated $1.56M sold.

Fortress Investment Group first reported a position in PRTK in Q1 2016 and held it in 26 quarters. The position peaked at $10.9M in Q3 2017. 72 funds tracked by Wall St. Rank hold PRTK as of Q3 2022.

Fortress Investment Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Fortress Investment Group sold 809,651 Paratek Pharmaceuticals, Inc. shares in Q3 2022, an estimated $1.56M.
Fortress Investment Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2016 and held it in 26 quarters.
Fortress Investment Group's Paratek Pharmaceuticals, Inc. position peaked at $10.9M in Q3 2017.
72 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2022.

Based on Fortress Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.